Kelly Faulk, MD
Assistant Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation
Medical School:
Department: Pediatrics-Heme/Onc and Bone Marrow Transplantation
- MD, University of Colorado Denver School of Medicine (2012)
- MSCS, University of Colorado Health Sciences Center (2019)
- BA, University of Colorado - Boulder (CO) (2007)
- University of Colorado (Children's Hospital Colorado) Program (2012)
- University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2015)
- University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2018)
- University of Colorado (Children's Hospital Colorado) Program, Experimental Therapeutics (2019)
Department: Pediatrics-Heme/Onc and Bone Marrow Transplantation
Professional Titles
- Instructor
Publications
- Faulk KE, Anderson-Mellies A, Cockburn M, Green AL. Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015. PLoS One. 2020; 15(4)e0230824.
- The Safety of SARS-Cov-2 Vaccines in Persons with a Known History of Pegaspargase Allergy: A Single Institution Experience. The Journal of Allergy and Clinical Immunology: In Practice, accepted with revisions.
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
- Children's Hospital Colorado
Specialty Information
Specialties
- Pediatric Hematology / Oncology, Board Certification
- Pediatrics, Board Certification
- Cancers - Leukemia (Childhood)
- Cancers
- Cancers - Pediatric Cancer
Clinical Interests
My clinical interest is in early phase clinical trials and translational research in novel pediatric cancer treatments, with a particular emphasis on high risk pediatric cancers and hematologic malignancies.
My clinical interest is in early phase clinical trials and translational research in novel pediatric cancer treatments, with a particular emphasis on high risk pediatric cancers and hematologic malignancies.
General Information
Medical Schools:
- MD, University of Colorado Denver School of Medicine (2012)
Graduate Schools:
- MSCS, University of Colorado Health Sciences Center (2019)
Undergraduate Schools:
- BA, University of Colorado - Boulder (CO) (2007)
Internships:
- University of Colorado (Children's Hospital Colorado) Program (2012)
Residency Programs:
- University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2015)
Fellowships:
- University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2018)
- University of Colorado (Children's Hospital Colorado) Program, Experimental Therapeutics (2019)
Department: Pediatrics-Heme/Onc and Bone Marrow Transplantation